Um are you contextualizing the studies properly ?

Anti viral therapies should be used ( and discussed ) clearly within two substrates :
Preambulatory care, and ambulatory .

Now contrast this ( and all data I will be happy to provide ) with the lack of preambulatory protocol used at least in the USA. People test positive , hey send them home and tell them to isolate and wait , that is when they SHOULD exactly be using therapeutics . Most of your data points invariably have come from when they are showing symptoms, not before
All this testing and no protocol . Of course the tests don't work so this creates different issues in data points .

there are a few clinics that offer preambulatory care using anti viral therapeutics .
This is the data you want to look at .

Just a hint